Shelly E Sakiyama-Elbert Selected Research

Spinal Cord Injuries (Spinal Cord Injury)

1/2019	Derivation of Specific Neural Populations From Pluripotent Cells for Understanding and Treatment of Spinal Cord Injury.
12/2018	Transplantation of Neural Progenitors and V2a Interneurons after Spinal Cord Injury.
1/2017	Stem cells for spinal cord injury: Strategies to inform differentiation and transplantation.
12/2015	Combination therapy of stem cell derived neural progenitors and drug delivery of anti-inhibitory molecules for spinal cord injury.
9/2015	Sustained dual drug delivery of anti-inhibitory molecules for treatment of spinal cord injury.
10/2010	Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI.
1/2010	Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delay the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury.
1/2010	Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI.
12/2009	Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury.
1/2009	The differentiation of embryonic stem cells seeded on electrospun nanofibers into neural lineages.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shelly E Sakiyama-Elbert Research Topics

Disease

15	Spinal Cord Injuries (Spinal Cord Injury) 01/2019 - 08/2004
5	Inflammation (Inflammations) 01/2021 - 04/2015
4	Wounds and Injuries (Trauma) 01/2017 - 01/2008
3	Peripheral Nerve Injuries 12/2015 - 05/2009
2	Cicatrix (Scar) 01/2018 - 01/2010
2	Gliosis 09/2015 - 07/2006
1	Ischemia 09/2015
1	Parkinson Disease (Parkinson's Disease) 05/2014

Drug/Important Bio-Agent (IBA)

7	FibrinIBA 09/2015 - 08/2004
5	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2017 - 05/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2015 - 09/2007
1	EnzymesIBA 01/2021
1	Proteoglycans (Proteoglycan)IBA 01/2021
1	Connective Tissue Growth FactorIBA 01/2018
1	Chondroitin Sulfate ProteoglycansIBA 09/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2015
1	CytokinesIBA 04/2015
1	Oxidopamine (6 Hydroxydopamine)IBA 05/2014
1	SiliconesIBA 05/2009
1	Nerve Growth Factors (Neurotrophins)IBA 07/2006
1	GelsIBA 08/2004

Therapy/Procedure

5	Transplantation 12/2018 - 01/2009
5	Therapeutics 01/2017 - 08/2004
2	Cell Transplantation 01/2021 - 01/2019
1	Sutures (Suture) 01/2018
1	Treatment Delay 12/2009